Cargando…

SARS-CoV-2 and the pandemic of COVID-19

SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30,...

Descripción completa

Detalles Bibliográficos
Autores principales: Adil, Md Tanveer, Rahman, Rumana, Whitelaw, Douglas, Jain, Vigyan, Al-Taan, Omer, Rashid, Farhan, Munasinghe, Aruna, Jambulingam, Periyathambi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016996/
https://www.ncbi.nlm.nih.gov/pubmed/32788312
http://dx.doi.org/10.1136/postgradmedj-2020-138386
_version_ 1784907487207489536
author Adil, Md Tanveer
Rahman, Rumana
Whitelaw, Douglas
Jain, Vigyan
Al-Taan, Omer
Rashid, Farhan
Munasinghe, Aruna
Jambulingam, Periyathambi
author_facet Adil, Md Tanveer
Rahman, Rumana
Whitelaw, Douglas
Jain, Vigyan
Al-Taan, Omer
Rashid, Farhan
Munasinghe, Aruna
Jambulingam, Periyathambi
author_sort Adil, Md Tanveer
collection PubMed
description SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30, 2020, a total of 5 899 866 positive cases were registered including 364 891 deaths. SARS-CoV-2 primarily targets the lung and enters the body through ACE2 receptors. Typical symptoms of COVID-19 include fever, cough, shortness of breath and fatigue, yet some atypical symptoms like loss of smell and taste have also been described. 20% require hospital admission due to severe disease, a third of whom need intensive support. Treatment is primarily supportive, however, prognosis is dismal in those who need invasive ventilation. Trials are ongoing to discover effective vaccines and drugs to combat the disease. Preventive strategies aim at reducing the transmission of disease by contact tracing, washing of hands, use of face masks and government-led lockdown of unnecessary activities to reduce the risk of transmission.
format Online
Article
Text
id pubmed-10016996
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-100169962023-05-23 SARS-CoV-2 and the pandemic of COVID-19 Adil, Md Tanveer Rahman, Rumana Whitelaw, Douglas Jain, Vigyan Al-Taan, Omer Rashid, Farhan Munasinghe, Aruna Jambulingam, Periyathambi Postgrad Med J Review SARS-CoV-2 is a virus that is the cause of a serious life-threatening disease known as COVID-19. It was first noted to have occurred in Wuhan, China in November 2019 and the WHO reported the first case on December 31, 2019. The outbreak was declared a global pandemic on March 11, 2020 and by May 30, 2020, a total of 5 899 866 positive cases were registered including 364 891 deaths. SARS-CoV-2 primarily targets the lung and enters the body through ACE2 receptors. Typical symptoms of COVID-19 include fever, cough, shortness of breath and fatigue, yet some atypical symptoms like loss of smell and taste have also been described. 20% require hospital admission due to severe disease, a third of whom need intensive support. Treatment is primarily supportive, however, prognosis is dismal in those who need invasive ventilation. Trials are ongoing to discover effective vaccines and drugs to combat the disease. Preventive strategies aim at reducing the transmission of disease by contact tracing, washing of hands, use of face masks and government-led lockdown of unnecessary activities to reduce the risk of transmission. Oxford University Press 2020-08-11 /pmc/articles/PMC10016996/ /pubmed/32788312 http://dx.doi.org/10.1136/postgradmedj-2020-138386 Text en © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Review
Adil, Md Tanveer
Rahman, Rumana
Whitelaw, Douglas
Jain, Vigyan
Al-Taan, Omer
Rashid, Farhan
Munasinghe, Aruna
Jambulingam, Periyathambi
SARS-CoV-2 and the pandemic of COVID-19
title SARS-CoV-2 and the pandemic of COVID-19
title_full SARS-CoV-2 and the pandemic of COVID-19
title_fullStr SARS-CoV-2 and the pandemic of COVID-19
title_full_unstemmed SARS-CoV-2 and the pandemic of COVID-19
title_short SARS-CoV-2 and the pandemic of COVID-19
title_sort sars-cov-2 and the pandemic of covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016996/
https://www.ncbi.nlm.nih.gov/pubmed/32788312
http://dx.doi.org/10.1136/postgradmedj-2020-138386
work_keys_str_mv AT adilmdtanveer sarscov2andthepandemicofcovid19
AT rahmanrumana sarscov2andthepandemicofcovid19
AT whitelawdouglas sarscov2andthepandemicofcovid19
AT jainvigyan sarscov2andthepandemicofcovid19
AT altaanomer sarscov2andthepandemicofcovid19
AT rashidfarhan sarscov2andthepandemicofcovid19
AT munasinghearuna sarscov2andthepandemicofcovid19
AT jambulingamperiyathambi sarscov2andthepandemicofcovid19